跳至主要内容
临床试验/EUCTR2018-002319-86-ES
EUCTR2018-002319-86-ES进行中(未招募)1 期

Dominantly Inherited Alzheimer Network - DIA

Fundació Clínic per a la Recerca Biomèdica0 个研究点目标入组 45 人开始时间: 2018年11月16日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • 1. Signature of informed consent by the participant and companion of the study before carrying out any procedure related to the study
  • 2. Age = 18 years and the child of an individual affected (clinically or by tests) of genetic Alzheimer's disease in a pedigree with a known mutation causing genetic Alzheimer's disease.
  • 3. Cognitively normal (Clinical dementia Rating scale, CDR = 0) or with cognitive impairment in mild phase (CDR 0.5 or 1).
  • 4. The participant has identified two people who are not their blood siblings who can serve as companions to the study.
  • 5. Sufficient knowledge of the Castilian language (equivalent to 6th grade of primary school).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 15

排除标准

  • 1. The participant has a medical or psychiatric illness that would interfere according to clinical criteria in the initial evaluation and / or follow-up evaluations.
  • 2. The participant has an advanced cognitive impairment that requires admission to a long-term care center.
  • 3. The recruitment of a subject with cognitive impairment must be pre-approved by the Coordinating Group of DIAN.
  • 4. Women who are pregnant or breast-feeding or who have planned to become pregnant during the study period

研究者

发起方
Fundació Clínic per a la Recerca Biomèdica

相似试验